What can be done for children under the age of 6 years who suffer from migraines? —Sharon R. Bass, MD, Morgan City, La. Recommendations for migraine therapy in children include lifestyle modifications ...

For millions of children and teenagers, migraine isn’t just “a bad headache.” It’s a debilitating neurological condition that can disrupt school performance, social life, and emotional well-being. Now ...

CINCINNATI (WKRC) - A medication previously available only for adults is now on the market for children to help reduce migraines. Recent research focused on children aged six to 17 and examined a ...

Another difference is that a migraine attack may not last as long in children, with a duration of maybe only two or three hours rather than the standard minimum of four hours in adults. With those ...

REUTERS - A drug-free placebo pill prevents migraines in children and teens just as well as most headache medicines, according to a U.S. study. Researchers published in JAMA Pediatrics found that only ...

Headaches are very common in children and teens. In fact, more than half will suffer from headaches at some point, and by 18 years the majority of adolescents have had them. And while most headaches ...

CINCINNATI (WKRC) - A device long used by adults to manage migraines is now available for children as young as eight years old, offering new hope for young sufferers. For 9-year-old Savannah Stremel, ...

Please provide your email address to receive an email when new articles are posted on . Fremanezumab targets calcitonin gene-related peptides. The placebo group had one more migraine and headache day ...

Teva Pharmaceutical Industries’ TEVA late-stage study evaluating Ajovy (fremanezumab) for the prevention of episodic migraine in pediatric and adolescent patients met its primary efficacy endpoint.

Chronic migraine causes 15 or more headache days per month for more than 3 months, and parenting activities like loud noises, physical exertion, and irregular sleep can trigger migraine episodes.

The US Food and Drug Administration (FDA) has approved zolmitriptan nasal spray (Zomig, Impax Specialty Pharma) for the acute treatment of migraine with or without aura in children 12 years of age and ...